The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma

Roberts, J.A., Bradding, P., Britten, K.M., Walls, A.F., Wilson, S., Gratziou, C., Holgate, S.T. and Howarth, P.H. (1999) The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma European Respiratory Journal, 14, (2), pp. 275-282. (PMID:10515396).


Full text not available from this repository.


Salmeterol xinafoate is an inhaled long-acting beta2-adrenoceptor agonist recently introduced for the treatment of asthma. Both in vitro and animal studies suggest that it may have anti-inflammatory activities of benefit in this disease. To assess this directly, the effects of 6 weeks' treatment with salmeterol on indices of clinical activity, airway dysfunction and inflammation in subjects with stable atopic asthma were investigated. In a double blind study, asthmatic patients were randomized to 6 weeks' treatment with either salmeterol 50 microg twice daily (n=14) or placebo (n=12). They underwent bronchoscopy with bronchoalveolar lavage (BAL) and bronchial biopsy immediately before starting treatment and again after 6 weeks. Treatment with salmeterol improved clinical indices of asthma activity, but there were no changes in BAL differential cell counts or mediator levels, and no change in T-cell numbers or activation status. In the biopsy specimens there were no changes in numbers of inflammatory cells, sub-basement membrane collagen deposition or mast cell degranulation. Regular treatment with salmeterol improves clinical indices of asthma but has no effect on the underlying inflammatory process. These findings strengthen guideline recommendations that long-acting beta2-agonists should not be prescribed as sole antiasthma medication.

Item Type: Article
ISSNs: 0903-1936 (print)
Subjects: Q Science > QR Microbiology > QR180 Immunology
R Medicine > RB Pathology
R Medicine > RF Otorhinolaryngology
ePrint ID: 190951
Date :
Date Event
August 1999Published
Date Deposited: 20 Jun 2011 14:51
Last Modified: 18 Apr 2017 01:57
Further Information:Google Scholar

Actions (login required)

View Item View Item